medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2018, Number 1

<< Back Next >>

Rev Latin Infect Pediatr 2018; 31 (1)

Excerpt from the Document: «Updating the treatment of tuberculosis in children»

Mellado PMJ, Santiago GB, Baquero-Artigao F, Moreno PD, Piñeiro PR, Méndez EA, Ramos AJT, Gómez-Pastrana DD, Noguera JA

Language: Spanish
References: 21
Page: 5-7
PDF size: 174.73 Kb.


Text Extraction

No abstract.


REFERENCES

  1. World Health Organization. Global Tuberculosis Report 2016. Geneva, Switzerland; 2015.

  2. World Health Organization, Centre for Disease Control and Prevention, UNICEF et al. Roadmap for childhood tuberculosis. Towards Zero Deat. Geneva; 2013: WHO/HTM/TB/2013.12. [Access in March 2017]. Available in: www.who.org.

  3. European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2016. Stockholm; 2016. [Access in March 2017] Available in: www.ecdc.org.

  4. Del Rosal T, Baquero-Artigao F, García-Miguel MJ, Méndez-Echevarría A, López G, Aracil FJ et al. Impact of immigration on pulmonary tuberculosis in Spanish children: a three-decade review. Pediatr Infect Dis J. 2010; 29 (7): 648-651.

  5. Calzada-Hernández J, Anton-López J, Bou-Torrent R, Iglesias-Jiménez E, Ricart-Campos S, Martín de Carpi J et al. Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study. Pediatr Rheumatol Online J. 2015; 13: 54.

  6. Santiago-García B, Blázquez-Gamero D, Baquero-Artigao F, Ruíz-Contreras J, Bellón JM, Muñoz-Fernández MA et al. Pediatric extrapulmonary tuberculosis: clinical spectrum, risk factors and diagnostic challenges in a low prevalence region. Pediatr Infect Dis J. 2016; 35 (11): 1175-1181.

  7. Santiago B, Baquero-Artigao F, Mejías A, Blázquez D, Jiménez MS, Mellado-Peña MJ; EREMITA Study Group. Pediatric drug-resistant tuberculosis in Madrid: family matters. Pediatr Infect Dis J. 2014; 33 (4): 345-350.

  8. American Academy of Pediatrics. Tuberculosis. In: Kimberlin D, Brady M, Jackson M, Long S, eds. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL, 2015.

  9. National Institute for Health and Clinical Excellence N. Tuberculosis. London, UK; 2016. [Acces in February 2017] Available in: www.nice.org.uk.

  10. World Health Organization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. Geneva; 2014: WHO/HTM/TB/2014.03.

  11. Baquero-Artigao F, Mellado Peña MJ, del Rosal RT, Noguera JA, Goncé MA, de la Calle Fernández MM y cols. Guía de la Sociedad Española de Infectología Pediátrica sobre tuberculosis en la embarazada y el recién nacido (I): Epidemiología y Diagnóstico. An Pediatr. 2015; 83: e1-285.

  12. World Health Organization, The End TB Stratagy. Guidelines on the management of latent tuberculosis infection. Geneva; 2015:WHO/HTYM/TB/2015.01.

  13. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016; 63 (7): e147-e195.

  14. Piñeiro PR, Santiago GB, Rodríguez MB, Baquero AF, Fernández LC, Goretti LM y cols. Recomendaciones para la elaboración y administración de fármacos antituberculosos en niños. Segunda fase del Proyecto Magistral de la Red Española de Estudio de la Tuberculosis Pediátrica (pTBred). An Pediatr (Barc). 2016; 85: e1-e11.

  15. Carazo GB, Moreno PD, Nuñez CE, Mesa FA, Martin CM, Obando PP et al. Paradoxical reaction in immunocompetent children with tuberculosis. Int J Infect Dis. 2016; 51: 15-18.

  16. Seddon JA, Perez-Velez CM, Schaaf HS, Furin JJ, Marais BJ, Tebruegge M et al. Consensus statement on research definitions for drug-resistant tuberculosis in children. J Pediatric Infect Dis Soc. 2013; 2 (2): 1-10.

  17. World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. Geneva, Switzerland; 2016.

  18. Villarino ME, Dooley SW, Geiter LJ, Castro KG, Snider DE Jr. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 1992; 41: 61-71.

  19. Seddon J, Fred D, Amanullah F, Burzynski J, Keshavjee S, Starke JR. Post-Exposure Management of Multidrug-Resistant Tuberculosis Contacts: evidence based recommendations. Policy Brief No.1. Dubay, United Arab Emirates; 2015.

  20. Seddon JA, Hesseling AC, Finlayson H, Fielding K, Cox H, Hughes J et al. Preventive therapy for child contacts of MDR TB: a prospective cohort study. Clin Infect Dis. 2013; 57 (12): 1676-1684.

  21. European Centre for Disease Prevention and Control. Management of contacts of MDR TB and XDR TB patients. Stockholm; 2012.




2020     |     www.medigraphic.com